Skip to contentApplication 079179
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | IMATINIB MESYLATE | IMATINIB MESYLATE | TABLET;ORAL | EQ 100MG BASE | No | No |
| 002 | IMATINIB MESYLATE | IMATINIB MESYLATE | TABLET;ORAL | EQ 400MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0904-6621 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6621 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6621 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6621 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6901 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6901 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6901 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 0904-6901 | Imatinib Mesylate | Imatinib Mesylate | Major Pharmaceuticals | ANDA | Current |
| 50268-426 | Imatinib Mesylate | Imatinib Mesylate | AvPAK | ANDA | Current |
| 50268-426 | Imatinib Mesylate | Imatinib Mesylate | AvPAK | ANDA | Current |
| 50268-427 | Imatinib Mesylate | Imatinib Mesylate | AvPAK | ANDA | Current |
| 50268-427 | Imatinib Mesylate | Imatinib Mesylate | AvPAK | ANDA | Current |
| 50268-427 | Imatinib Mesylate | Imatinib Mesylate | AvPAK | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2900 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |
| 60505-2901 | Imatinib Mesylate | Imatinib Mesylate | Apotex Corp | ANDA | Current |